PPMD's Blog – October 2012 Archive (3)

Today's (October 31st) MD STARnet Webinar Postponed due to Hurricane

Dear Friends,

Due to the recent hurricane we are going to postpone tomorrow's MD STARnet webinar.  



We will be in touch regarding the new date. Sorry for the inconvenience. 

Best, 

Ryan Fischer

PPMD

EVENT DETAILS…

Webinar: MD STARnet
Continue

Added by PPMD on October 30, 2012 at 1:00pm — No Comments

Prosensa Announces Progress on Exon Skipping Compounds for the Treatment of Duchenne Muscular Dystrophy

New release from Prosensa:

£10m in milestone payments received from GlaxoSmithKline

 

Leiden, The Netherlands, 23 October 2012 – Prosensa, the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high unmet need, has selected clinical candidates for two more compounds for the treatment of Duchenne muscular dystrophy (DMD) and has been granted…

Continue

Added by PPMD on October 23, 2012 at 12:35pm — 2 Comments

Full 48-week Phase IIb data from eteplirsen study in Duchenne presented at World Muscle Society

Dr. Jerry Mendell, Director of the Centers for Gene Therapy and Muscular Dystrophy at Nationwide Children's Hospital and principal investigator of the Phase IIb eteplirsen study, presented the full set of 48-week data from…

Continue

Added by PPMD on October 16, 2012 at 9:00am — No Comments

Monthly Archives

2018

2017

2016

2015

2014

2013

2012

2011

2010

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2019   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service